Isabelle Gross

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (5)

Manuela Tavian

UMR INSERM 1109

Blandine GUFFROY

Institut de Cancérologie Strasbourg

Laurent Miguet

Matteo Negroni

CNRS Délégation Alsace

Alain Jung

Institut de Cancérologie Strasbourg

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Isabelle Gross

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (5)

Manuela Tavian

Blandine GUFFROY

Laurent Miguet

Matteo Negroni

Alain Jung

Make your next move.

Isabelle Gross

Research Interests

Explore related searches

Contact this professor

Articles (10)

The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.

Morpho-functional analysis of patient-derived xenografts reveals differential impact of gastric cancer and chemotherapy on the tumor ecosystem, affecting immune check point, metabolism, and sarcopenia

Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer

CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer

Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms

Bypassing the Resistance Mechanisms of the Tumor Ecosystem by Targeting the Endoplasmic Reticulum Stress Pathway Using Ruthenium- and Osmium-Based Organometallic Compounds: An Exciting Long-Term Collaboration with Dr. Michel Pfeffer

CDX2 regulates ACE expression in blood development and leukemia cells.

CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors

The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms.

Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms

Collaborators (5)

Manuela Tavian

Blandine GUFFROY

Laurent Miguet

Matteo Negroni

Alain Jung

Make your next move.